Rupert Davies
About Rupert Davies
Rupert Davies serves as the Executive Director of Translational Medicine at Alpine Immune Sciences, Inc., bringing extensive experience from his previous roles in academia and the biotechnology industry.
Current Role at Alpine Immune Sciences
Rupert Davies serves as the Executive Director of Translational Medicine at Alpine Immune Sciences, Inc., a position he has held since 2022. In this role, he focuses on bridging the gap between preclinical research and clinical development, ensuring that innovative therapies are effectively translated into clinical applications. His work contributes to advancing the company's mission in immunotherapy and related fields.
Previous Experience in Biopharmaceuticals
Prior to his current role, Rupert Davies held various positions in the biopharmaceutical sector. He worked at Zymeworks Inc. in several capacities, including Senior Director of Translational Sciences and Director of Pharmacokinetics. His tenure at Zymeworks spanned from 2015 to 2022, during which he contributed to the development of oncology therapeutics. He also served as Manager of Preclinical Development at Sarepta Therapeutics from 2010 to 2012.
Academic Background and Research
Rupert Davies has a robust academic background in engineering and bioengineering. He earned a Bachelor of Science in Civil and Environmental Engineering from the University of Michigan from 1991 to 1995. He then pursued a PhD in Bioengineering at the University of Utah, completing his studies from 1998 to 2004. Following this, he conducted postdoctoral research at the University of Washington from 2004 to 2007, further enhancing his expertise in the field.
Career Development in Academia and Industry
Rupert Davies began his career in academia, working as a Senior Fellow at the University of Washington from 2004 to 2007. He transitioned to industry roles, including a position as Manager of R&D at Implicit Bioscience from 2007 to 2010. His career reflects a blend of academic research and practical application in the biopharmaceutical industry, with significant contributions to preclinical and translational sciences.